Gilead Sciences Inc GILD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:43 AM EDT
65.19quote price arrow down-0.32 (-0.48%)
Volume
1,573,207
52 week range
64.63 - 87.86
Loading...
  • Open65.75
  • Day High65.80
  • Day Low64.89
  • Prev Close65.51
  • 52 Week High87.86
  • 52 Week High Date01/19/24
  • 52 Week Low64.63
  • 52 Week Low Date04/26/24

Key Stats

  • Market Cap81.232B
  • Shares Out1.25B
  • 10 Day Average Volume8.65M
  • Dividend3.08
  • Dividend Yield4.72%
  • Beta0.22
  • YTD % Change-19.36

KEY STATS

  • Open65.75
  • Day High65.80
  • Day Low64.89
  • Prev Close65.51
  • 52 Week High87.86
  • 52 Week High Date01/19/24
  • 52 Week Low64.63
  • 52 Week Low Date04/26/24
  • Market Cap81.232B
  • Shares Out1.25B
  • 10 Day Average Volume8.65M
  • Dividend3.08
  • Dividend Yield4.72%
  • Beta0.22
  • YTD % Change-19.36

RATIOS/PROFITABILITY

  • EPS (TTM)0.36
  • P/E (TTM)181.30
  • Fwd P/E (NTM)18.07
  • EBITDA (TTM)11.631B
  • ROE (TTM)2.52%
  • Revenue (TTM)27.45B
  • Gross Margin (TTM)75.78%
  • Net Margin (TTM)1.66%
  • Debt To Equity (MRQ)109.43%

EVENTS

  • Earnings Date08/01/2024
  • Ex Div Date06/14/2024
  • Div Amount0.77
  • Split Date-
  • Split Factor-

Profile

MORE
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. It is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP...
Daniel O'Day
Chairman of the Board, Chief Executive Officer
Andrew Dickinson
Chief Financial Officer
Deborah Telman
Executive Vice President - Corporate Affairs, General Counsel
Address
333 LAKESIDE DR
Foster City, CA
94404
United States

Top Peers

SYMBOLLASTCHG%CHG
GSK
GSK plc
43.20+0.63+1.48%
BMY
Bristol-Myers Squibb Co
43.94-0.27-0.62%
ZTS
Zoetis Inc
169.53+11.03+6.96%
AMGN
Amgen Inc
276.49-0.88-0.32%
VRTX
Vertex Pharmaceuticals Inc
402.96+0.82+0.20%